Chris Leiter is the Founder & General Partner at Atria Ventures – partnering with exceptional founders from inception to seed stages building at the nexus of technology & biology. The firm invests in category-defining companies at the intersection of technology and biology with a focus on B2B software in pharma, digital and AI/ML-enabled tools & platforms for clinical trials and drug development, biomanufacturing, decentralized science, pharmacy, patient access platforms and social determinants of health.

Prior to Atria, Chris worked at dRx Capital, Pear VC and Gaingels, having led or supported over 50+ early-stage techbio and digital health financings, and helped build Gaingels’ top-performing biotech+healthcare practice. Prior to his investing career, Chris was a founder of Guardtime Health – engineering the rails for clinical trials data management. He started his career in consulting at KPMG, where he was the Global COO for the firm’s healthcare practice.

Chris is a co-founder of Series Q, a non-profit focused on supporting LGBTQ+ tech founders. He lectures at MIT on healthcare, venture capital and biotech (see course notes here). Chris holds an M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology, an MS.c. from the London School of Economics, and a B.A. from Richmond University. In his free time, he enjoys being in the mountains (cycling, skiing, or hiking) and is a house music junkie (deep, progressive, tribal).